Companies Dominating the Neurotrophins Landscape
- Genentech, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Regeneron Pharmaceuticals, Inc.
- Biogen Inc.
- Amgen Inc.
- Eli Lilly and Company
- Novartis International AG
- Pfizer Inc.
- Roche Holding AG
- Johnson & Johnson
- AbbVie Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of neurotrophins is evaluated at USD 7.77 billion.
The neurotrophins market size was valued at USD 7.32 billion in 2024 and is set to exceed USD 18.29 billion by 2037, registering over 7.3% CAGR during the forecast period i.e., between 2025-2037. Increasing demand for healthcare sector will fuel the market growth.
Asia Pacific industry is poised to account for largest revenue share of 40% by 2037, impelled by surge in collaborative research endeavors in the region.
The major players in the market are Genentech, Inc., Regeneron Pharmaceuticals, Inc., Biogen Inc., Amgen Inc., Eli Lilly and Company, Novartis International AG, and others.
